CCL19 and chronic kidney disease: In the chemokine signaling and cytokine–cytokine receptor interaction pathways, CXCL6 showed greater levels while CCL3L1, CCL19, CCL25, and PPBP showed decreased levels in CKD patients than healthy controls.